A Retrospective Evaluation of a Nurse Practitioner-Led Cancer Genetics Program
Genetics research is not routinely disseminated into gastroenterology clinical practice, thereby missing opportunities to identify hereditary cancer syndromes. To identify effectiveness outcomes of a nurse practitioner–led cancer genetics program. The Donabedian model was used to identify program ef...
Gespeichert in:
Veröffentlicht in: | Journal for nurse practitioners 2022-03, Vol.18 (3), p.276-284 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Genetics research is not routinely disseminated into gastroenterology clinical practice, thereby missing opportunities to identify hereditary cancer syndromes.
To identify effectiveness outcomes of a nurse practitioner–led cancer genetics program.
The Donabedian model was used to identify program effectiveness outcomes. A screening tool was administered to 10,324 patients.
Pathogenic variant carriers were identified in 35% of patients tested. Program screening and surveillance met effectiveness outcomes criteria; tumor testing as a method of screening did not. Nurse practitioner–led cancer genetics programs integrate evidence-based guidelines and provide person-centered care to enhance quality care outcomes.
•The Donabedian model allowed for the delineation of structure and process to identify cancer genetics quality care outcome successes and deficiencies.•The nurse practitioner (NP)-led cancer genetic screening and surveillance program met all quality outcomes.•Using NPs for hereditary cancer syndrome screening and cancer surveillance is a highly effective method of delivering preventative cancer services.•This model of care can be implemented in all NP practices, anticipating similar outcomes.•Adherence scores were higher than expected as attributed to shared decision-making. |
---|---|
ISSN: | 1555-4155 1878-058X |
DOI: | 10.1016/j.nurpra.2021.12.013 |